Prostate cancer is the most common male malignancy in Morocco and a growing public health concern across the Middle East and North Africa (MENA) region. Despite a rising incidence, the majority of prostate cancer cases in Morocco and similar low- and middle-income settings continue to be diagnosed at advanced stages, contributing to poor survival outcomes and a disproportionately high mortality-to-incidence ratio compared with high-income countries. This mini-review examines the epidemiological burden of prostate cancer in Morocco, identifies the multilevel barriers contributing to late diagnosis, including the absence of organized screening programs, limited public awareness, healthcare system constraints, and socioeconomic factors, and discusses current national cancer control efforts and future perspectives for improving early detection.
M. A. Elafari, Mohamed Amine Zaki, A. Mamad et al.· SAS Journal of Medicine· 0 citations
As of 2026, AS may be considered in highly selected patients, but only after rigorous initial characterization with multiparametric MRI and appropriate biopsy assessment, clear patient counseling, and intensified follow-up.
Y. Alaoui, O. Bentaleb, S. Lafdali et al.· Scholars Journal of Medical...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.